QPWM
Quadrant Private Wealth Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.07K | Hold |
10,000
| – | – | ﹤0.01% | 249 |
|
2025
Q1 | $4.52K | Hold |
10,000
| – | – | ﹤0.01% | 229 |
|
2024
Q4 | $5.03K | Hold |
10,000
| – | – | ﹤0.01% | 242 |
|
2024
Q3 | $9.05K | Hold |
10,000
| – | – | ﹤0.01% | 243 |
|
2024
Q2 | $9.97K | Sell |
10,000
-5,000
| -33% | -$4.99K | ﹤0.01% | 252 |
|
2024
Q1 | $22.2K | Buy |
15,000
+5,000
| +50% | +$7.4K | 0.01% | 236 |
|
2023
Q4 | $10.9K | Hold |
10,000
| – | – | ﹤0.01% | 232 |
|
2023
Q3 | $11.8K | Hold |
10,000
| – | – | ﹤0.01% | 222 |
|
2023
Q2 | $14.1K | Hold |
10,000
| – | – | ﹤0.01% | 246 |
|
2023
Q1 | $15K | Hold |
10,000
| – | – | ﹤0.01% | 247 |
|
2022
Q4 | $11.7K | Buy |
+10,000
| New | +$11.7K | ﹤0.01% | 242 |
|
2022
Q2 | $16K | Hold |
10,000
| – | – | 0.01% | 206 |
|
2022
Q1 | $15K | Hold |
10,000
| – | – | 0.01% | 208 |
|
2021
Q4 | $25K | Hold |
10,000
| – | – | 0.01% | 201 |
|
2021
Q3 | $25K | Hold |
10,000
| – | – | 0.01% | 192 |
|
2021
Q2 | $29K | Hold |
10,000
| – | – | 0.01% | 193 |
|
2021
Q1 | $24K | Hold |
10,000
| – | – | 0.01% | 192 |
|
2020
Q4 | $18K | Hold |
10,000
| – | – | 0.01% | 183 |
|
2020
Q3 | $9K | Hold |
10,000
| – | – | ﹤0.01% | 175 |
|
2020
Q2 | $9K | Hold |
10,000
| – | – | 0.01% | 181 |
|
2020
Q1 | $8K | Hold |
10,000
| – | – | 0.01% | 147 |
|
2019
Q4 | $9K | Buy |
+10,000
| New | +$9K | 0.01% | 112 |
|
2019
Q3 | – | Sell |
-10,000
| Closed | -$11K | – | 113 |
|
2019
Q2 | $11K | Hold |
10,000
| – | – | 0.01% | 105 |
|
2019
Q1 | $13K | Hold |
10,000
| – | – | 0.01% | 104 |
|
2018
Q4 | $9K | Hold |
10,000
| – | – | 0.01% | 96 |
|
2018
Q3 | $24K | Hold |
10,000
| – | – | 0.02% | 99 |
|
2018
Q2 | $21K | Hold |
10,000
| – | – | 0.02% | 99 |
|
2018
Q1 | $27K | Hold |
10,000
| – | – | 0.04% | 86 |
|
2017
Q4 | $22K | Buy |
+10,000
| New | +$22K | 0.02% | 94 |
|